Clinical Trial Update: To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study in healthy adults comparing the oral bioavailability of Bilastine 20 mg orally disintegrating tablet with Bilaxten (bilastine) 20 mg orally disint…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Bilastine (bilastine)
• Bilaxten (bilastine)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Allergic Rhino-Conjunctivitis, Urticaria | Phase 1 | Status: COMPLETED